MC38-B2m KO
Strain Information
表現型データ
Fig1. Detection of B2M expression on in vitro cultured cells of MC38-B2M-KO cell line by FACS.
Fig2. Detection of B2M expression on in vitro cultured cells of MC38-B2M-KO cell line by WB.
Fig3. In vivo validation of MC38-B2M-KO cells in C57BL/6 mice (n=6).
C57BL/6 mice were inoculated with MC38-B2M-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development.
Fig4. B2M expression in tumors after in vivo growth of MC38-B2M-KO in wild type C57BL/6 mice
The tumors were collected at day 18 post tumor cell inoculation.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
詳細